NSU and Immunotec Start Clinical Trial in Autism

Links shared publicly online about this topic.

401
total visits

NSU and Immunotec Start Clinical Trial in Autism

Nova Southeastern University (NSU) and the dietary supplement company Immunotec announced today that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder.

View full resource at newswise.com

Tags: Autism Spectrum Disorder, Autism, Diet and Nutrition, Supplement, Clinical Trial, Healthy Living, News

Most Recently Shared on March 30, 2011 at 7:55 pm By:

Thom Canalichio

#health news: NSU and Immunotec Start Clinical Trial in Autism: Nova Southeastern University (NSU) and the dieta... http://bit.ly/g0ZKtu

1 year ago...

Retweet

Favorite

NSU And Immunotec Start Clinical Trial In Autism - QualityPoint Technologies

qualitypointtech.net — “Nova Southeastern University (NSU) and the dietary supplement company Immunotec announced that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder. The 2-year study will investigate the effects of a cysteine-rich whey protein isolate in children diagnosed with autism. The primary function of this research is to establish whether taking a 90-day diet of cysteine-rich whey proteins (which comes in a powder f” View full resource at qualitypointtech.net